During the last session, ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s traded shares were 1.13 million, with the beta value of the company hitting 0.89. At the end of the trading day, the stock’s price was $14.05, reflecting an intraday gain of 7.66% or $1.0. The 52-week high for the SPRY share is $16.50, that puts it down -17.44 from that peak though still a striking 81.85% gain since the share price plummeted to a 52-week low of $2.55. The company’s market capitalization is $1.36B, and the average intraday trading volume over the past 10 days was 0.95 million shares, and the average trade volume was 1.09 million shares over the past three months.
ARS Pharmaceuticals Inc (SPRY) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. SPRY has a Sell rating from 0 analyst(s) out of 4 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 4 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -0.15.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ARS Pharmaceuticals Inc (NASDAQ:SPRY) trade information
ARS Pharmaceuticals Inc (SPRY) registered a 7.66% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 7.66% in intraday trading to $14.05, hitting a weekly high. The stock’s 5-day price performance is 17.08%, and it has moved by -1.33% in 30 days. Based on these gigs, the overall price performance for the year is 88.84%. The short interest in ARS Pharmaceuticals Inc (NASDAQ:SPRY) is 10.96 million shares and it means that shorts have 7.39 day(s) to cover.
The consensus price target of analysts on Wall Street is $22, which implies an increase of 36.14% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $18 and $30 respectively. As a result, SPRY is trading at a discount of -113.52% off the target high and -28.11% off the low.
ARS Pharmaceuticals Inc (SPRY) estimates and forecasts
Statistics show that ARS Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. ARS Pharmaceuticals Inc (SPRY) shares have gone up 66.08% during the last six months, with a year-to-date growth rate less than the industry average at -15.79% against 20.00. Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 6.30% this quarter and then drop -285.70% in the quarter after that. In the rating firms’ projections, revenue will increase 13,933.30% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 500k as predicted by 4 analyst(s). Meanwhile, a consensus of 4 analyst(s) estimates revenue growth to 3.21M by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -1.44%. While earnings are projected to return -12.72% in 2024.
SPRY Dividends
ARS Pharmaceuticals Inc is due to release its next quarterly earnings in October. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ARS Pharmaceuticals Inc (NASDAQ:SPRY)’s Major holders
ARS Pharmaceuticals Inc insiders own 23.46% of total outstanding shares while institutional holders control 64.34%, with the float percentage being 84.06%.
